S. Ashwell

发表

Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo‐controlled trial

U. Dashora, L. Sibal, S. Ashwell, 2007, Diabetic medicine : a journal of the British Diabetic Association.

Microbiological evaluation of resection margins of the infected diabetic foot ulcer

S. Ashwell, E. Scott, M. Macauley, 2020, Diabetic medicine : a journal of the British Diabetic Association.

The efficacy and safety of lanreotide Autogel in patients with acromegaly previously treated with octreotide LAR.

O. M. Edwards, S. Ashwell, J. Bevan, 2004, European journal of endocrinology.

Twice‐daily compared with once‐daily insulin glargine in people with Type 1 diabetes using meal‐time insulin aspart

S. Ashwell, P. Home, J. Gebbie, 2006, Diabetic medicine : a journal of the British Diabetic Association.

An overview of insulin glargine

P. Home, S. Ashwell, 2002, Diabetes/metabolism research and reviews.

Insulin glargine: the first clinically useful extended-action insulin analogue

P. Home, S. Ashwell, 2001, Expert opinion on pharmacotherapy.

Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in people with Type 1 diabetes

S. Ashwell, C. Bradley, J. Stephens, 2008 .

Study protocol for a multicentre comparative diagnostic accuracy study of tools to establish the presence and severity of peripheral arterial disease in people with diabetes mellitus: the DM PAD study

K. Khunti, J. Norrie, J. Shalhoub, 2022, BMJ Open.

Artefactual serum hyperkalaemia and hypercalcaemia in essential thrombocythaemia

S. Ashwell, M. Howard, I. Holbrook, 2000, Journal of clinical pathology.

Residual Adrenal Function in Autoimmune Addison’s Disease—Effect of Dual Therapy With Rituximab and Depot Tetracosactide

S. Pearce, S. Ashwell, B. Vaidya, 2019, The Journal of clinical endocrinology and metabolism.

Iatrogenic Cushing's syndrome secondary to combined oral contraceptive pill in a patient with congenital adrenal hyperplasia

S. Ashwell, Yaasir H Mamoojee, Satish Artham, 2015 .

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross‐over trial in people with Type 1 diabetes

S. Heller, R. Bilous, D. Hepburn, 2006, Diabetic medicine : a journal of the British Diabetic Association.

Optimal timing of injection of once‐daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal‐times

S. Ashwell, J. Gebbie, P. Home, 2006, Diabetic medicine : a journal of the British Diabetic Association.